IP Verse

Sanofi Biotechnology competitive analysis

Latest publications and patents of Sanofi Biotechnology New

Explore the latest publications and patents granted to Sanofi Biotechnology, showcasing their recent innovations and technological advancements.

Last updated on: Sep 30, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Sanofi Biotechnology
EP3506931	Jul 31, 2024	Methods For Preventing Or Treating Allergy By Administering An Il-4R Antagonist	Granted And Under Opposition
EP3889181	Apr 24, 2024	Methods For Treating Atopic Dermatitis By Administering An Il-4R Antagonist	Granted And Under Opposition
EP3110848	Feb 14, 2024	Methods For Treating Skin Infection By Administering An Il-4R Antagonist	Granted And Under Opposition
EP3515465	Feb 7, 2024	Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R Inhibitor	Granted And Under Opposition
EP3973987	Jan 10, 2024	Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist	Granted And Under Opposition
EP4011915	Nov 15, 2023	Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist	Granted And Under Opposition
EP3703818	Nov 1, 2023	Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist	Granted And Under Opposition
EP3470432	Oct 6, 2021	Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist	Revoked
EP3107575	Sep 1, 2021	Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist	Granted And Under Opposition
EP2892927	May 9, 2018	Methods For Treating Atopic Dermatitis By Administering An Il-4R Antagonist	Revoked

Latest patents of Sanofi Biotechnology opposed by its competitors

Explore Sanofi Biotechnology's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP3506931	Jul 31, 2024	Methods For Preventing Or Treating Allergy By Administering An Il-4R Antagonist	4
EP3889181	Apr 24, 2024	Methods For Treating Atopic Dermatitis By Administering An Il-4R Antagonist	7
EP3110848	Feb 14, 2024	Methods For Treating Skin Infection By Administering An Il-4R Antagonist	5
EP3515465	Feb 7, 2024	Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R Inhibitor	7
EP3973987	Jan 10, 2024	Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist	6
EP4011915	Nov 15, 2023	Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist	6
EP3703818	Nov 1, 2023	Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist	7
EP3470432	Oct 6, 2021	Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist	4
EP3107575	Sep 1, 2021	Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist	3
EP2892927	May 9, 2018	Methods For Treating Atopic Dermatitis By Administering An Il-4R Antagonist	1

Latest PTAB cases involving Sanofi Biotechnology

Discover the latest PTAB cases involving Sanofi Biotechnology, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Sanofi Biotechnology with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
SANOFI BIOTECHNOLOGY	-	50	-	-	Non-Active
BOULT WADE TENNANT	52	-	-	-	Highly Aggressive
HAMPTON KNOWLES	24	-	-	-	Highly Aggressive
SECERNA	11	-	-	-	Highly Aggressive